Almasan AG
  • Landing
  • Home
  • About
  • Portfolio
  • Services
  • Insights
  • Contact
  • Cookie Policy (EU)
Select Page

On our best behaviour: Why driving behaviour change is the next big focus for pharma companies in chronic diseases

by Aleksandar Ruzicic | Aug 13, 2025 | Healthcare

“Drugs don’t work in patients that don’0t take them” Everett Koop, former US Surgeon General. This famous quote from 1985 has perhaps never been more relevant. It is estimated that non-adherence to medication is associated with almost 200,000...

Towards a smoker segmentation tool: Analysis of predictors for risk of harm, readiness to quit and optimal methods to quit smoking

by Aleksandar Ruzicic | Aug 12, 2025 | Healthcare

Although most people who smoke cigarettes want to quit, stopping smoking is notoriously difficult. There are a huge number of individual factors – including smoking history and behaviors, biological, psychological, socioeconomic and demographic factors – that drive...

Assessing the impact of smoking cessation interventions on smoking prevalence – Lessons from five successful and five less successful countries

by Aleksandar Ruzicic | Aug 11, 2025 | Healthcare

Smoking remains the single largest cause of preventable death and the biggest cause of cancer worldwide (WHO Report on the Global Tobacco Epidemic. 2008). It is also the cause of many preventable illnesses, including cardiovascular disease, stroke and chronic...

Rare diseases: the seamless go-to-market model

by Aleksandar Ruzicic | Aug 7, 2025 | Business Optimization

Collectively, rare diseases are anything but rare. Combined, they represent a huge market; one that has been a major focus of interest and investment from the biopharmaceutical industry ever since the US Orphan Drug Act offered financial, legal and legislative...

KAM 2.0: Elevating Key Account Management beyond country limits

by Aleksandar Ruzicic | Aug 6, 2025 | Business Optimization

As the landscape of healthcare stakeholders and influencers becomes more complex and multifaceted, so the need for managing key accounts grows. Pharma companies are trying to reach different stakeholders with different priorities, often in different locations. Key...
« Older Entries
Next Entries »
    Website built by The Free Website Guys🚀
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}